Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M698Revenue $M3.4Net Margin (%)-178.3Z-Score-1.8
Enterprise Value $M663EPS $-0.8Operating Margin %-161.2F-Score3
P/E(ttm))0Cash Flow Per Share $-0.5Pre-tax Margin (%)-178.3Higher ROA y-yY
Price/Book40.810-y EBITDA Growth Rate %-24.9Quick Ratio7.0Cash flow > EarningsN
Price/Sales21.15-y EBITDA Growth Rate %-11.8Current Ratio7.1Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-41.4Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)3ROE % (ttm)-273.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M123ROI % (ttm)-167.3Gross Margin Increase y-yN

Gurus Latest Trades with OREX

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
OREXJohn Burbank 2013-12-31 Sold Out -0.15%$4.72 - $6.83
$ 5.56-1%Sold Out0
OREXJohn Burbank 2012-09-30 Buy 0.2%$3.77 - $7.39
$ 5.564%New holding, 750000 sh.750,000
OREXGeorge Soros 2012-06-30 Sold Out -0.03%$3.16 - $6.37
$ 5.5648%Sold Out0
OREXGeorge Soros 2012-03-31 Buy 0.03%$1.68 - $5.01
$ 5.5679%New holding, 500000 sh.500,000
OREXJean-Marie Eveillard 2010-09-30 Sold Out -0.01%$3.9 - $6.77
$ 5.5612%Sold Out0
OREXJean-Marie Eveillard 2010-06-30 Add$4.05 - $7.04
$ 5.560%Add 74.07%470,000
OREXJean-Marie Eveillard 2010-03-31 Add$5.9 - $7.66
$ 5.56-15%Add 22.73%270,000
OREXJean-Marie Eveillard 2009-12-31 Add0.01%$6.44 - $9.39
$ 5.56-27%Add 83.33%220,000
OREXJean-Marie Eveillard 2009-09-30 Buy 0.01%$5.2 - $10.34
$ 5.56-30%New holding, 120000 sh.120,000
OREXBill Gates 2009-06-30 Sold Out $1.89 - $5.21
$ 5.5674%Sold Out0
OREXJean-Marie Eveillard 2007-09-30 Sold Out $13.21 - $15.88
$ 5.56-62%Sold Out0
OREXJean-Marie Eveillard 2007-06-30 Buy $13.75 - $17.94
$ 5.56-65%New holding, 21400 sh.21,400
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

OREX is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!

OREX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Turner Heather DSVP, Gen. Counsel & Secretary 2014-12-02Sell22,643$6-9.83view
Turner Heather DSVP, Gen. Counsel & Secretary 2014-11-25Sell31,388$5.83-7.2view
BOCK LOUIS CDirector 2014-11-18Buy1,325$5.58-3.05view
BOCK LOUIS CDirector 2014-11-12Buy27,052$5.57-2.87view
Turner Heather DVP, Gen. Counsel & Secretary 2014-09-22Sell300,000$4.4721.03view
NARACHI MICHAELPresident and CEO 2014-09-15Buy50,000$4.7813.18view
Hagan Joseph PSr. VP, Corporate Development 2014-09-15Buy5,000$4.6915.35view
Hagan Joseph PChief Business Officer 2013-07-31Sell12,000$7.8-30.64view
Hagan Joseph PChief Business Officer 2013-07-26Sell10,000$7.4-26.89view
Booth Mark DChief Commercial Officer 2013-07-26Sell64,767$7.55-28.34view

Press Releases about OREX :

    Quarterly/Annual Reports about OREX:

    News about OREX:

    Articles On GuruFocus.com
    Revisiting Arena, Orexigen, And VIVUS: Shareholders Can Recoup Their Losses By Invest In MannKind Aug 19 2014 
    Weekly CEO Sells Highlight: Orexigen Therapeutics Inc, Gas Natural Inc, The Middleby Corporation, an Jul 15 2012 
    Weekly CEO Sells Highlight: Gas Natural Inc, Encore Bancshares Inc, Staples Inc, and Orexigen Therap Jul 08 2012 
    Arena Facing Increased Pressure from Peers Apr 23 2012 
    Arena Could Dip If Lorcaserin Fails Again Apr 22 2012 
    Vivus Could Rocket on Success of Qnexa Apr 13 2012 
    Steve Cohen Bets On Orexigen Ahead of FDA Approval Jan 31 2011 
    Orexigen Therapeutics Inc. Reports Operating Results (10-Q) Nov 04 2010 
    Orexigen Therapeutics Inc. Reports Operating Results (10-Q) Aug 06 2010 
    cooldecency99 note on OREX May 01 2010 

    More From Other Websites
    Coverage initiated on Orexigen Therapeutics by RBC Capital Mkts Jan 23 2015
    Orexigen Therapeutics, Inc. (OREX): New Analyst Report from Zacks Equity Research - Zacks Equity... Jan 16 2015
    Orexigen CEO: Excited about obesity drug progress Jan 13 2015
    OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Jan 12 2015
    Orexigen Therapeutics to Present at the J.P. Morgan 2015 Healthcare Conference Jan 08 2015
    Orexigen Therapeutics to Present at the J.P. Morgan 2015 Healthcare Conference Jan 08 2015
    FDA clears Novo Nordisk's weight loss drug Saxenda Dec 23 2014
    New highs! The S&P 500 closes just below its prior record close... Dec 19 2014
    OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Other Events Dec 19 2014
    Orexigen Therapeutics Gains On Diet Pill Nod From European Committee Dec 19 2014
    Orexigen's 'Goldilocks' Weight-Loss Pill is Just Right for European Regulators Dec 19 2014
    Orexigen's Mysimba™ (naltrexone HCl / bupropion HCl prolonged release) Receives Positive CHMP... Dec 19 2014
    European regulators recommend approval of Orexigen's obesity pill Dec 19 2014
    Orexigen's Mysimba™ (naltrexone HCl / bupropion HCl prolonged release) Receives Positive CHMP... Dec 19 2014
    Six Biotech and Technology Stocks With Strong Technical Set-Ups Dec 18 2014
    Bio-Twitter Sentiment Favors European Orexigen Obesity Pill Approval Dec 17 2014
    Obesity Pill Upstart Orexigen Therapeutics Gaining on Rivals Dec 12 2014
    These 4 Biotech Stocks Have Been On Fire Dec 08 2014
    Why Orexigen Therapeutics (OREX) Stock Might be a Great Pick Dec 05 2014
    Earnings Estimates Moving Higher for Orexigen (OREX): Time to Buy? Dec 03 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial